New Delhi: India's drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), is planning to review the ceiling prices of knee implants in a meeting likely to be held next week, as discussions intensify between the government, manufacturers, and patient advocacy groups.

The NPPA had capped the prices of knee implants in 2017 to curb exorbitant costs, bringing down overall procedure expenses for patients by up to 70%. The move was hailed as a landmark step in medical device price regulation. The move, made under the extraordinary powers granted by the Drug Price Control Order (DPCO), 2013, was hailed as a landmark intervention in making joint replacement surgeries more affordable across India.

The Authority has since been reviewing industry feedback and extending the n

See Full Page